While the coronavirus has impacted millions of Americans across the United States, it has hit the elderly population particularly hard. In fact, more than 40 percent of coronavirus deaths in the U.S. have been linked to long-term care facilities, according to a New York Times survey. In an effort to bring those numbers down, pharmaceutical company Eli Lilly, in partnership with the National Institutes of Health (NIH), has just launched a late-stage antibody treatment trial focusing on residents and staff at nursing homes. 

"COVID-19 has had a devastating impact on nursing home residents," Lilly's chief scientific officer Daniel Skovronsky said in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals."

The trial is expected to enroll up to 2,400 participants who live or work at a facility and have recently been diagnosed with the disease. The trial will evaluate the safety and success of using LY-CoV555, a potent, neutralizing antibody that works against the spike protein of the novel coronavirus. The trial will look at whether a single dose of the antibody treatment reduces the rate of infection over four weeks as well as symptoms over eight weeks.

"The importance of these kinds of therapies for people like the elderly or immunocompromised is that they can provide the hope and the safety net that these people really need right now," said Andrew Adams, vice president of new therapeutic modalities & COVID-19 research at Eli Lilly, who is overseeing the trial. "I think people in those populations are really desperate and looking for something to help with the coronavirus."

Eli Lilly is taking its trial on the road with customized mobile research units that can travel  directly to areas that are experiencing outbreaks. 

"This is an interesting solution, to bring the medicine to these vulnerable patients," said Adams. "This lets us be flexible and move these trials around the country, tracking these trials as we come across them."

Adams said he is hoping Eli Lilly will have results on the efficacy of these antibodies in the fourth quarter of this year. Even if successful, though, he says research for a vaccine needs to continue.

"These have to be thought of as more of a bridge, where a vaccine provides long-term protection in terms of years of immunity, where we will provide hopefully in the range of months with these types of treatments. We hope this to be a short-term bridge to the long-term effective vaccination," he said.

Share:
More In Science
Washed Ashore: Art to Save the Sea
Plastic pollution is a problem that experts say is only getting worse. One organization is looking to change that. Activists want to save the beauty of our oceans, with the beauty of art. Brad Parks, conservation education director of the Washed Ashore project, joins Cheddar News to discuss.
Mask Mandate for Travelers No Longer in Effect
The federal mask mandate for planes and other public transportation has been grounded. A federal judge in Florida struck down the nationwide requirement saying it exceeds health officials' authority. Dr. Sampson Davis, emergency medicine physician, joins Cheddar News to discuss.
UPSIDE Foods Raises $400 Million to Commercialize Cultivated Meat at Scale
UPSIDE foods, a company that makes cultivated meat products, recently raised $400 million in a Series C round. UPSIDE says it's developing a way to grow real meat, poultry, and seafood, without the need to raise animals for human consumption. It's a process that gets the attention of some big-name backers, including Bill Gates and Richard Branson. Dr. Uma Valeti, Founder and CEO of UPSIDE Foods, joins Cheddar News' Closing Bell to discuss.
Rights of Nature Says Nature Has Basic Rights to Exist
An increasing number of countries are recognizing "Rights of Nature", a legal movement that says ecosystems and species have basic rights to exist and flourish. Grant Wilson, executive director at Earth Law Center joins Cheddar News to explain what the movement is aiming to achieve.
Tech Firms Like Alphabet, Meta Commit $925M to Carbon Removal Initiative Frontier
Removing carbon from our atmosphere has become a goal for scientists and entrepreneurs around the world, and while many have begun to develop promising technology solutions, a few big names in tech, including Stripe, Alphabet, Shopify, Meta and McKinsey, are committing nearly $1 billion dollars to fund carbon removal technology through 2030 through a new initiative called Frontier, an advanced market commitment to incentive following through on development. Hannah Bebbington, the head of strategy for Frontier, joined Cheddar News to discuss. "What Frontier aims to do is help get this market on track by sending that strong demand signal such that we can scale up capacity really significantly in the next couple of years," she said.
Autumn Peltier to Canada: Less Talk, More Action on Clean Water Access
Autumn Peltier, an indigenous water activist, joined Cheddar News to talk about the lack of access to clean water among indigenous communities in Canada. “I say the government to hold themselves accountable for the promises that they make because Canada and indigenous people have a long history of broken promises and they still continue to this day to keep breaking promises with the nation's people," she said. "Less talk and more action is very much expected from me."
Bill Gates' Breakthrough Energy Sees Promise in Tough Climate Tech Sectors
Jonah Goldman, the managing director at Bill Gates-founded Breakthrough Energy, joined Cheddar News to talk about the promising growth in the climate change-conscious investments the organization has made over the years. ”I mean when we're looking at some of the hard to abate technologies and cement and steel and aviation fuel, all of those have promising pathways that weren't there again just a few years ago," he said. "We invest across all of the technology areas that are driving emissions, greenhouse gas emissions and there really are exciting products and technologies coming out in almost every one of those sectors.”
USDA Partnering With Farmers to Promote Climate-Smart Commodities
Robert Bonnie, farm production and conservation undersecretary for the USDA, spoke to Cheddar about climate-smart strategies to help farmers reduce carbon emissions from agriculture. "We share the costs of installing those practices on their lands in ways that will protect the climate and maintain agricultural productivity, and we're also partnering with farmers to draw in private investment in greenhouse gas emissions reductions provided by agriculture and forestry," he said. The hope is to get farmers and ranchers to produce climate-smart commodities to lessen the impact of climate change.
Load More